Please login to the form below
Medicines for Europe
This page shows the latest Medicines for Europe news and features for those working in and with pharma, biotech and healthcare.
EFPIA-EURORDIS joint statement published on patient access to medicines for rare diseases
The EFPIA-EURORDIS joint statement on patient access to medicines for rare diseases across Europe has been published. ... Commenting on the publication of the statement, EFPIA’s director general, Nathalie Moll, said: “EFPIA and EURORDIS share the
Latest news
-
Nordic Capital acquires ADVANZ PHARMA for $846m
UK-based ADVANZ PHARMA has a strategic focus on complex medicines in Europe, with expertise in anti-infectives and endocrinology therapy areas. ... This deal is fantastic news for ADVANZ PHARMA and our goal of becoming the go-to partner for complex
-
EMA begins rolling review of AZ’s COVID-19 vaccine candidate
Agency has started evaluating data from non-clinical laboratory studies. The Europe Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has begun its first ‘rolling review’ of
-
Novartis’ Mayzent and Roche’s Polivy lead CHMP recommendations
medicines recommended for use in Europe on Friday. ... Mayzent (siponimoid), developed by Swiss pharma Novartis, has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for the
-
Who's calling the shots in European healthcare?
EPHA says one of its core goals is to use ‘evidence-based advocacy’ to secure ‘better and affordable medicines for Europe by questioning and reforming the current pharmaceutical business model and ... Natsis believes this is a pointer to the future
-
European elections: Eurosceptics and Greens rise, but big parties hold on
Moves to set out a strong coalition against pharma and its high prices for specialist medicines is also growing in Europe and beyond, with the issue gaining much attention at the ... Nevertheless, the new Commission is likely to continue its
More from news
Approximately 1 fully matching, plus 33 partially matching documents found.
Latest Intelligence
-
The sound of silence puts the squeeze on generics and biosimilars
A market worth £78bn is expected to open to competition by 2020 as big gun biologics fall off patent, but Adrian van den Hoven, director general of Medicines for Europe (pictured ... Medicines for Europe is also trying to soften the Supplementary
-
Interview: Cesar Rodriguez, Janssen
We cannot forget the fact that the UK has already among the lowest prices for medicines in Europe, and this is something that everybody should know. ... But this is not happening in all cases. “We still have one of the lowest rates of uptake for new
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
EFPIA confirms first and second vice-presidents
That includes working with governments to reduce access delays and improve the availability of medicines for patients across Europe. ... Our ambition is for Europe to be a world leader in life science.
-
Pfizer's Andrew Thomas takes up UK comms agency role
Prior to joining the Creston Health Group agency he served at Pfizer as strategic communications lead for primary care medicines across Europe and Canada. ... During this time, he handled a portfolio that included many of the company's highest profile
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- MHRA to introduce new UK clinical trials framework
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- MSD’s Keytruda to be made available in England for advanced cervical cancer patients
- Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
- Improving cardiovascular disease care and awareness
- PMGroup announces launch of new recruitment platform PharmaRole
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- The state of pharma customer experience
- GSK and CureVac to advance mRNA COVID-19 and flu vaccine candidates
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
